A fresh era of earnings growth may be on the horizon.

Moderna (MRNA) drew fresh attention after appointing experienced financial executive Michael McDonnell to its Board and Audit ...

Moderna's growth story is just beginning.

Moderna's flu vaccine may not fuel a further recovery for the hard-hit COVID-19-affected stock.

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Moderna wasn’t one of them. The 10 stocks tha ...

CAMBRIDGE, MA / ACCESS Newswire / July 16, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first ...

Alex Hogan is STAT’s senior multimedia producer and host of STATus Report, STAT’s weekly video series. You can follow him on Bluesky. The story of the biotech company Moderna almost reads like a ...

French pharmaceutical company Sanofi has filed lawsuits against Pfizer and Moderna, claiming the companies used patented ...

CAMBRIDGE, MA / ACCESS Newswire / / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, July 31, 2026 to report its second ...

Moderna said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company grapples with uncertainty in the vaccine market. In a ...

Moderna has countered a patent-infringement lawsuit brought by biotech company CureVac in Delaware federal court over its ...